Literature DB >> 25394620

Dynamics of syndesmophyte growth in AS as measured by quantitative CT: heterogeneity within and among vertebral disc spaces.

Sovira Tan1, Jianhua Yao1, John A Flynn1, Lawrence Yao1, Michael M Ward2.   

Abstract

OBJECTIVE: Syndesmophytes in AS typically grow slowly, but it is not known whether growth is uniform among syndesmophytes in the same intervertebral disc space (IDS) or among different IDSs in the same patient or if growth is heterogeneous. We examined the dynamics of syndesmophyte growth over 24 months using CT, with the main aim of determining if syndesmophytes in the same IDS or the same patient grow at similar rates.
METHODS: We performed lumbar spine CT scans on 33 patients and measured syndesmophytes in four IDSs using a validated computer algorithm. Scans were done at baseline and 12 and 24 months. We compared absolute and percentage changes in volume from baseline to 12 months and to 24 months among syndesmophytes in the same IDS and among four IDSs of each patient. We also examined whether growth among all IDSs differed between study years.
RESULTS: Among 60 IDSs with at least two syndesmophytes at baseline (range 2-6), there was substantial heterogeneity in both absolute (P < 0.0001) and percentage (P = 0.0002) volume increases among syndesmophytes in the same IDS. Several IDSs had both syndesmophytes with no growth and syndesmophytes that increased by >100 mm(3). Similarly there was significant heterogeneity in syndesmophyte growth among IDSs of individual patients. Increases in total syndesmophyte volume for each patient also tended to differ between study years (P = 0.07).
CONCLUSION: Syndesmophytes in AS do not all grow continuously. Rates of growth over 24 months commonly differ between syndesmophytes in the same IDS and between different IDSs in the same patient, suggesting that local factors regulate syndesmophyte growth. Published by Oxford University Press on behalf of the British Society for Rheumatology 2014. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  ankylosing spondylitis; computed tomography; syndesmophyte

Mesh:

Year:  2014        PMID: 25394620      PMCID: PMC4447840          DOI: 10.1093/rheumatology/keu423

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  22 in total

1.  Radiation dose reduction with Sinogram Affirmed Iterative Reconstruction technique for abdominal computed tomography.

Authors:  Mannudeep K Kalra; Mischa Woisetschläger; Nils Dahlström; Sarabjeet Singh; Maria Lindblom; Garry Choy; Petter Quick; Bernhard Schmidt; Martin Sedlmair; Michael A Blake; Anders Persson
Journal:  J Comput Assist Tomogr       Date:  2012 May-Jun       Impact factor: 1.826

2.  Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study.

Authors:  Astrid van Tubergen; Sofia Ramiro; Désirée van der Heijde; Maxime Dougados; Herman Mielants; Robert Landewé
Journal:  Ann Rheum Dis       Date:  2011-10-11       Impact factor: 19.103

3.  Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis.

Authors:  Praveena Chiowchanwisawakit; Robert G W Lambert; Barbara Conner-Spady; Walter P Maksymowych
Journal:  Arthritis Rheum       Date:  2011-08

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.

Authors:  Denis Poddubnyy; Hildrun Haibel; Joachim Listing; Elisabeth Märker-Hermann; Henning Zeidler; Jürgen Braun; Joachim Sieper; Martin Rudwaleit
Journal:  Arthritis Rheum       Date:  2012-05

6.  Improved precision of syndesmophyte measurement for the evaluation of ankylosing spondylitis using CT: a phantom and patient study.

Authors:  Sovira Tan; Jianhua Yao; Lawrence Yao; Michael M Ward
Journal:  Phys Med Biol       Date:  2012-07-02       Impact factor: 3.609

7.  Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome.

Authors:  Annelies Boonen; Bert vander Cruyssen; Kurt de Vlam; Serge Steinfeld; Clio Ribbens; Jan Lenaerts; Filip Van den Bosch; Herman Mielants; Lode Dewulf; Nathan Vastesaeger
Journal:  J Rheumatol       Date:  2009-05-15       Impact factor: 4.666

8.  The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients.

Authors:  Xenofon Baraliakos; Joachim Listing; Anna von der Recke; Jurgen Braun
Journal:  J Rheumatol       Date:  2009-03-30       Impact factor: 4.666

9.  IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.

Authors:  Jonathan P Sherlock; Barbara Joyce-Shaikh; Scott P Turner; Cheng-Chi Chao; Manjiri Sathe; Jeff Grein; Daniel M Gorman; Edward P Bowman; Terrill K McClanahan; Jennifer H Yearley; Gérard Eberl; Christopher D Buckley; Robert A Kastelein; Robert H Pierce; Drake M Laface; Daniel J Cua
Journal:  Nat Med       Date:  2012-07-01       Impact factor: 53.440

10.  A novel approach to the analysis of human growth.

Authors:  Antonio S Gliozzi; Caterina Guiot; Pier Paolo Delsanto; Dan A Iordache
Journal:  Theor Biol Med Model       Date:  2012-05-17       Impact factor: 2.432

View more
  4 in total

Review 1.  Syndesmophyte growth in ankylosing spondylitis.

Authors:  Sovira Tan; Runsheng Wang; Michael M Ward
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

Review 2.  Better Quantification of Syndesmophyte Growth in Axial Spondyloarthritis.

Authors:  Michael M Ward; Sovira Tan
Journal:  Curr Rheumatol Rep       Date:  2018-06-21       Impact factor: 4.592

Review 3.  Nonsteroidal Antiinflammatory Drugs as Potential Disease-Modifying Medications in Axial Spondyloarthritis.

Authors:  Runsheng Wang; Joan M Bathon; Michael M Ward
Journal:  Arthritis Rheumatol       Date:  2020-02-24       Impact factor: 15.483

4.  Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.

Authors:  Hsu-Wen Tseng; Tibor T Glant; Matthew A Brown; Tony J Kenna; Gethin P Thomas; Allison R Pettit
Journal:  BMC Musculoskelet Disord       Date:  2017-05-30       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.